Clinical analysis of 5-year survival and recurrence in giant retroperitoneal liposarcoma after surgery  

作　　者：Huan Deng Bo Cao Hao Cui Runkai Chen Hanghang Li Ruiyang Zhao Lin Chen Bo Wei 

机构地区：[1]Medical School of Chinese People’s Liberation Army,Beijing 100853,China [2]Department of General Surgery,The First Medical Center,Chinese People’s Liberation Army General Hospital,Beijing 100853,China

出　　处：《Chinese Medical Journal》2023年第3期373-375,共3页中华医学杂志（英文版）

基　　金：supported by the National Natural Science Foundation of China(No.82073192);the National Key Research and Development Project of China(No.2019YFB1311505).

摘　　要：To the Editor:Retroperitoneal liposarcoma(RLS)pertains to one of the rare malignant tumors originated from the retroperitoneum.It is evaluated as the most common type of retroperitoneal sarcoma.RLS can be divided into four subtypes according to the pathological classification,which includes well-differentiated liposarcoma(WDL),dedifferentiated liposarcoma(DDL),myxoid cell liposarcoma(MLS),and pleomorphic liposarcoma(PLS).

关 键 词：SARCOMA RETROPERITONEAL PERITONEAL 

分 类 号：R735.4[医药卫生—肿瘤]